In these updates, UCSF Health and John Muir Health specialists in treatments for numerous cancers – including breast, lung, bladder and colon cancer – unpack last year's influential trials, several of which established new standards of care for specific patient populations. The speakers note design details and shed light on relevance to specific populations – for example, patients with high-risk, early-stage breast cancer. Learn about therapeutic advances for limited-stage small cell lung cancer, PSMA-targeting radioligand therapy for prostate cancer, and how liver transplantation can significantly improve survival for some patients with unresectable colorectal liver metastases. Bonus: Get CME credits for watching!
Published
March 28, 2025
Created by
